Abbisko And Merck KGaA MANEUVER Pimicotinib Towards Approval

 
• By Elizabeth Cairns

Pimicotinib’s Phase III data in tenosynovial giant cell tumor are better than its rivals but the fight for a small number of patients will be fierce.

Conceptual image of increasing value of money shown by a coin from small to large number

More from Clinical Trials

More from Anticancer